Call Us08045479576
Montelukast Sodium

Montelukast Sodium

35000 INR/Kilograms

Product Details:

  • Solubility Water Soluble
  • Ph Level 5-9
  • Boiling point 750.5
  • Smell Other
  • Heavy Metal (%) not available
  • Particle Size 50
  • Loss on Drying not more than 0.5%
  • Click to View more
X

Montelukast Sodium Price And Quantity

  • 1-5 Kilograms
  • 30000.00 - 35000.00 INR/Kilograms
  • 35000 INR/Kilograms

Montelukast Sodium Product Specifications

  • Medicine Grade
  • Pharmaceutical Intermediates
  • 151767-02-1
  • 145 to 148
  • C35H35ClNNaO3S
  • 608.17 Milligram (mg)
  • 3 Years
  • Other
  • Montelukast sodium
  • C35H35ClNNaO3S
  • 50
  • not available
  • Keep away from moisture
  • not more than 0.5%
  • 151767-02-1
  • Montelukast is used to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma in adults and children 12 months of age and older. Montelukast is also used to prevent bronchospasm (breathing difficulties) during exercise in adults and children 6 years of age and older
  • C35H35ClNNaO3S
  • 29349900
  • 750.5
  • 98%
  • Other
  • 5-9
  • Water Soluble
  • White to off-white crystalline powder
  • Powder

Montelukast Sodium Trade Information

  • MUMBAI port
  • Cash Against Delivery (CAD) Letter of Credit (L/C) Letter of Credit at Sight (Sight L/C) Cash in Advance (CID) Cash Advance (CA)
  • 2500 Kilograms Per Month
  • 3-7 Days
  • Yes
  • Free samples are available
  • DRUM
  • Australia North America South America Eastern Europe Western Europe Middle East Africa Asia Central America
  • ISO ,GMP

Product Description

The high quality Montelukast sodium produced in GMP site at Gujarat, India, can be supplied in several packaging options. The pure and effective product is exported to several countries worldwide.

Montelukast Sodium Properties:

  • CAS No.: 151767-02-1
  • Formula: C35H35ClNNaO3S
  • Molecular Weight: 608.2 g/mol
  • Synonyms: Cyclopropaneacetic acid,1-[[[(1R)-1-[3-[(1E)-2-(7-chloro-2- quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy- 1-methylethyl)phenyl]propyl]thio]methyl]-,monosodium salt; MK 476; Singulair (TN);Singulair;sodium 2-[1-[[(1R)-1-[3-[2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetate
  • Boiling Point: 750.5 °C at 760 mmHg
  • Flash Point: 407.7 °C
  • Appearance: White to off-white crystalline powder

Introduction of product:


A leukotriene receptor antagonist, montelukast can be used in asthma therapy, preventing exercise-induced bronchoconstriction, and in treating allergic rhinitis. 

How does it work:


The chemicals in your body that narrow your airways are stopped by LTRAs. Chemically, they are called leukotrienes. The drug prevents narrowing of your airways (caused by inflammation). This prevents asthma attacks and makes breathing easier. Montelukast belongs to the family of drugs called leukotriene receptor antagonists. It blocks leukotriene D4 in the lungs, resulting in a decrease in inflammation and relaxation of smooth muscle.

Applications Or where it is used:


It reduces symptoms associated with asthma and prevents wheezing and shortness of breath (such as asthma). As well as preventing breathing problems during exercise (bronchospasm), it is also used before exercise. Inhalers such as the quick relief inhaler can be used less frequently with this medication.

How to use:


One tablet of montelukast is usually taken with or without food each day. Montelukast should be taken in the evening when treating asthma. Taking montelukast at least two hours before exercising can help prevent breathing difficulties.

Dosage of usage :


Asthma or allergy symptoms can usually be prevented with montelukast taken in the evening. Your doctor may advise you to take montelukast before exercising if exercise makes your asthma worse. Do not exceed 1 dose per day.

Side effects of Montelukast Sodium:

  • This drug is rare to cause very serious allergic reactions. You should consult your doctor if any of these symptoms appear, including: severe dizziness, rash, itching/swelling, or trouble breathing.
  • The most common side effects of montelukast are upper respiratory infection, diarrhea, stomach pain, earache or ear infection, flu, fever, headache, sore throat, cough, runny nose, and sinus infection.
  • Warnings and precautions while using this product:
  • Immediately stop taking montelukast if you experience any of the following symptoms: agitation, irritability, difficulty paying attention, unusual dreams, memory loss or forgetfulness, aggressive behavior, anxiety, confusion and hallucinations.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
+91
  • India (भारत)+91
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United States+1
  • China (中国)+86
  • Afghanistan (‫افغانستان‬‎)+93
  • Albania (Shqipëri)+355
  • Algeria (‫الجزائر‬‎)+213
  • American Samoa+1684
  • Andorra+376
  • Angola+244
  • Anguilla+1264
  • Antigua and Barbuda+1268
  • Argentina+54
  • Armenia (Հայաստան)+374
  • Aruba+297
  • Australia+61
  • Austria (Österreich)+43
  • Azerbaijan (Azərbaycan)+994
  • Bahamas+1242
  • Bahrain (‫البحرين‬‎)+973
  • Bangladesh (বাংলাদেশ)+880
  • Barbados+1246
  • Belarus (Беларусь)+375
  • Belgium (België)+32
  • Belize+501
  • Benin (Bénin)+229
  • Bermuda+1441
  • Bhutan (འབྲུག)+975
  • Bolivia+591
  • Bosnia and Herzegovina (Босна и Херцеговина)+387
  • Botswana+267
  • Brazil (Brasil)+55
  • British Indian Ocean Territory+246
  • British Virgin Islands+1284
  • Brunei+673
  • Bulgaria (България)+359
  • Burkina Faso+226
  • Burundi (Uburundi)+257
  • Cambodia (កម្ពុជា)+855
  • Cameroon (Cameroun)+237
  • Canada+1
  • Cape Verde (Kabu Verdi)+238
  • Caribbean Netherlands+599
  • Cayman Islands+1345
  • Central African Republic (République centrafricaine)+236
  • Chad (Tchad)+235
  • Chile+56
  • China (中国)+86
  • Christmas Island+61
  • Cocos (Keeling) Islands+61
  • Colombia+57
  • Comoros (‫جزر القمر‬‎)+269
  • Congo (DRC) (Jamhuri ya Kidemokrasia ya Kongo)+243
  • Congo (Republic) (Congo-Brazzaville)+242
  • Cook Islands+682
  • Costa Rica+506
  • Côte d’Ivoire+225
  • Croatia (Hrvatska)+385
  • Cuba+53
  • Curaçao+599
  • Cyprus (Κύπρος)+357
  • Czech Republic (Česká republika)+420
  • Denmark (Danmark)+45
  • Djibouti+253
  • Dominica+1767
  • Dominican Republic (República Dominicana)+1
  • Ecuador+593
  • Egypt (‫مصر‬‎)+20
  • El Salvador+503
  • Equatorial Guinea (Guinea Ecuatorial)+240
  • Eritrea+291
  • Estonia (Eesti)+372
  • Ethiopia+251
  • Falkland Islands (Islas Malvinas)+500
  • Faroe Islands (Føroyar)+298
  • Fiji+679
  • Finland (Suomi)+358
  • France+33
  • French Guiana (Guyane française)+594
  • French Polynesia (Polynésie française)+689
  • Gabon+241
  • Gambia+220
  • Georgia (საქართველო)+995
  • Germany (Deutschland)+49
  • Ghana (Gaana)+233
  • Gibraltar+350
  • Greece (Ελλάδα)+30
  • Greenland (Kalaallit Nunaat)+299
  • Grenada+1473
  • Guadeloupe+590
  • Guam+1671
  • Guatemala+502
  • Guernsey+44
  • Guinea (Guinée)+224
  • Guinea-Bissau (Guiné Bissau)+245
  • Guyana+592
  • Haiti+509
  • Honduras+504
  • Hong Kong (香港)+852
  • Hungary (Magyarország)+36
  • Iceland (Ísland)+354
  • India (भारत)+91
  • Indonesia+62
  • Iran (‫ایران‬‎)+98
  • Iraq (‫العراق‬‎)+964
  • Ireland+353
  • Isle of Man+44
  • Israel (‫ישראל‬‎)+972
  • Italy (Italia)+39
  • Jamaica+1876
  • Japan (日本)+81
  • Jersey+44
  • Jordan (‫الأردن‬‎)+962
  • Kazakhstan (Казахстан)+7
  • Kenya+254
  • Kiribati+686
  • Kosovo+383
  • Kuwait (‫الكويت‬‎)+965
  • Kyrgyzstan (Кыргызстан)+996
  • Laos (ລາວ)+856
  • Latvia (Latvija)+371
  • Lebanon (‫لبنان‬‎)+961
  • Lesotho+266
  • Liberia+231
  • Libya (‫ليبيا‬‎)+218
  • Liechtenstein+423
  • Lithuania (Lietuva)+370
  • Luxembourg+352
  • Macau (澳門)+853
  • Macedonia (FYROM) (Македонија)+389
  • Madagascar (Madagasikara)+261
  • Malawi+265
  • Malaysia+60
  • Maldives+960
  • Mali+223
  • Malta+356
  • Marshall Islands+692
  • Martinique+596
  • Mauritania (‫موريتانيا‬‎)+222
  • Mauritius (Moris)+230
  • Mayotte+262
  • Mexico (México)+52
  • Micronesia+691
  • Moldova (Republica Moldova)+373
  • Monaco+377
  • Mongolia (Монгол)+976
  • Montenegro (Crna Gora)+382
  • Montserrat+1664
  • Morocco (‫المغرب‬‎)+212
  • Mozambique (Moçambique)+258
  • Myanmar (Burma) (မြန်မာ)+95
  • Namibia (Namibië)+264
  • Nauru+674
  • Nepal (नेपाल)+977
  • Netherlands (Nederland)+31
  • New Caledonia (Nouvelle-Calédonie)+687
  • New Zealand+64
  • Nicaragua+505
  • Niger (Nijar)+227
  • Nigeria+234
  • Niue+683
  • Norfolk Island+672
  • North Korea (조선 민주주의 인민 공화국)+850
  • Northern Mariana Islands+1670
  • Norway (Norge)+47
  • Oman (‫عُمان‬‎)+968
  • Pakistan (‫پاکستان‬‎)+92
  • Palau+680
  • Palestine (‫فلسطين‬‎)+970
  • Panama (Panamá)+507
  • Papua New Guinea+675
  • Paraguay+595
  • Peru (Perú)+51
  • Philippines+63
  • Poland (Polska)+48
  • Portugal+351
  • Puerto Rico+1
  • Qatar (‫قطر‬‎)+974
  • Réunion (La Réunion)+262
  • Romania (România)+40
  • Russia (Россия)+7
  • Rwanda+250
  • Saint Barthélemy+590
  • Saint Helena+290
  • Saint Kitts and Nevis+1869
  • Saint Lucia+1758
  • Saint Martin (Saint-Martin (partie française))+590
  • Saint Pierre and Miquelon (Saint-Pierre-et-Miquelon)+508
  • Saint Vincent and the Grenadines+1784
  • Samoa+685
  • San Marino+378
  • São Tomé and Príncipe (São Tomé e Príncipe)+239
  • Saudi Arabia (‫المملكة العربية السعودية‬‎)+966
  • Senegal (Sénégal)+221
  • Serbia (Србија)+381
  • Seychelles+248
  • Sierra Leone+232
  • Singapore+65
  • Sint Maarten+1721
  • Slovakia (Slovensko)+421
  • Slovenia (Slovenija)+386
  • Solomon Islands+677
  • Somalia (Soomaaliya)+252
  • South Africa+27
  • South Korea (대한민국)+82
  • South Sudan (‫جنوب السودان‬‎)+211
  • Spain (España)+34
  • Sri Lanka (ශ්‍රී ලංකාව)+94
  • Sudan (‫السودان‬‎)+249
  • Suriname+597
  • Svalbard and Jan Mayen+47
  • Swaziland+268
  • Sweden (Sverige)+46
  • Switzerland (Schweiz)+41
  • Syria (‫سوريا‬‎)+963
  • Taiwan (台灣)+886
  • Tajikistan+992
  • Tanzania+255
  • Thailand (ไทย)+66
  • Timor-Leste+670
  • Togo+228
  • Tokelau+690
  • Tonga+676
  • Trinidad and Tobago+1868
  • Tunisia (‫تونس‬‎)+216
  • Turkey (Türkiye)+90
  • Turkmenistan+993
  • Turks and Caicos Islands+1649
  • Tuvalu+688
  • U.S. Virgin Islands+1340
  • Uganda+256
  • Ukraine (Україна)+380
  • United Arab Emirates (‫الإمارات العربية المتحدة‬‎)+971
  • United Kingdom+44
  • United States+1
  • Uruguay+598
  • Uzbekistan (Oʻzbekiston)+998
  • Vanuatu+678
  • Vatican City (Città del Vaticano)+39
  • Venezuela+58
  • Vietnam (Việt Nam)+84
  • Wallis and Futuna (Wallis-et-Futuna)+681
  • Western Sahara (‫الصحراء الغربية‬‎)+212
  • Yemen (‫اليمن‬‎)+967
  • Zambia+260
  • Zimbabwe+263
  • Åland Islands+358
Mobile number

Email

Other Products in 'Active Pharmaceuticals Ingredients (API)' category